S
Sakineh Ranji-Burachaloo
Researcher at Tehran University of Medical Sciences
Publications - 19
Citations - 244
Sakineh Ranji-Burachaloo is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Stroke & Randomized controlled trial. The author has an hindex of 6, co-authored 17 publications receiving 140 citations. Previous affiliations of Sakineh Ranji-Burachaloo include Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study.
Shima Shahjouei,Soheil Naderi,Soheil Naderi,Jiang Li,Ayesha Khan,Durgesh Chaudhary,Ghasem Farahmand,Shailesh Male,Christoph J. Griessenauer,Mirna Sabra,Stefania Mondello,Achille Cernigliaro,Faezeh Khodadadi,Apoorva Dev,Nitin Goyal,Sakineh Ranji-Burachaloo,Oluwaseyi Olulana,Venkatesh Avula,Seyed Amir Ebrahimzadeh,Orkhan Alizada,Mehmet Hanci,Askar Ghorbani,Alaleh Vaghefi far,Annemarei Ranta,Annemarei Ranta,Martin Punter,Martin Punter,Mahtab Ramezani,Nima Ostadrahimi,Georgios Tsivgoulis,Georgios Tsivgoulis,Paraskevi C. Fragkou,Peyman Nowrouzi-Sohrabi,Emmanouil Karofylakis,Sotirios Tsiodras,Saeideh Neshin Aghayari Sheikh,Alia Saberi,Mika Niemelä,Behnam Rezai Jahromi,Ashkan Mowla,Mahsa Mashayekhi,Reza Bavarsad Shahripour,Seyed Aidin Sajedi,Mohammad Ghorbani,Arash Kia,Nasrin Rahimian,Vida Abedi,Vida Abedi,Ramin Zand,Ramin Zand +49 more
TL;DR: The results of this multi-national study on hospitalized patients with Sars-CoV-2 infection indicated an overall stroke risk of 0.5% and the need for mechanical ventilation and the history of ischaemic heart disease are the independent predictors of stroke among SARS-Cov-2 patients.
Journal ArticleDOI
Identification of a large homozygous VPS13C deletion in a patient with early-onset Parkinsonism.
Hossein Darvish,Paloma Bravo,Abbas Tafakhori,Luis J. Azcona,Sakineh Ranji-Burachaloo,Amir Hossein Johari,Coro Paisán-Ruiz +6 more
TL;DR: Although both groups experienced similar frequencies of motor complications, PD patients with DM had developed motor complications 1 year earlier compared with the nondiabetic group, despite being matched for LED, disease duration, frequency of levodopa use, and number of PD medications.
Journal ArticleDOI
The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial
Mohammad Parohan,Payam Sarraf,Mohammad Hassan Javanbakht,Abbas Rahimi Foroushani,Sakineh Ranji-Burachaloo,Mahmoud Djalali +5 more
TL;DR: The results showed a significant effect of nano-curcumin and CoQ10 supplementation on frequency, severity, duration of migraine attacks and HDR compared to other groups, and suggest a possible synergistic effect on clinical features of migraine.
Journal ArticleDOI
Short-term curcumin supplementation enhances serum brain-derived neurotrophic factor in adult men and women: a systematic review and dose-response meta-analysis of randomized controlled trials.
Payam Sarraf,Mohammad Parohan,Mohammad Hassan Javanbakht,Sakineh Ranji-Burachaloo,Mahmoud Djalali +4 more
TL;DR: The significant positive impact of curcumin supplementation on BDNF levels indicates its potential use for neurological disorders that are associated with lowBDNF levels.
Journal ArticleDOI
Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials.
Mohammad Parohan,Payam Sarraf,Mohammad Hassan Javanbakht,Sakineh Ranji-Burachaloo,Mahmoud Djalali +4 more
TL;DR: Pooled analyses of available randomized clinical trials suggest that Coenzyme Q10 supplementation may reduce the frequency of migraine attacks per month without affecting the severity or duration of migraines.